<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02491437</url>
  </required_header>
  <id_info>
    <org_study_id>M13-625</org_study_id>
    <secondary_id>2012-002993-29</secondary_id>
    <nct_id>NCT02491437</nct_id>
  </id_info>
  <brief_title>A Study Comparing the Efficacy, Safety and Tolerability of Oral Dydrogesterone 30 mg Daily Versus Crinone 8% Intravaginal Progesterone Gel 90 mg Daily for Luteal Support in In-Vitro Fertilization (LOTUS II)</brief_title>
  <acronym>LOTUS II</acronym>
  <official_title>A Randomized, Open-label, Two-arm, Multicenter Study Comparing the Efficacy, Safety and Tolerability of Oral Dydrogesterone 30 mg Daily Versus Crinone 8% Intravaginal Progesterone Gel 90 mg Daily for Luteal Support in In-Vitro Fertilization (LOTUS II)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Abbott</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>PRA Health Sciences</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Datamap</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Abbott</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this randomized, two-arm and open label study is to demonstrate that the
      treatment of a daily dose of 3x10mg dydrogesterone orally is as effective and safe as the
      daily dose Crinone 8% intravaginal progesterone gel 90 mg for the luteal support in women who
      are unable to conceive a child and are undergoing IVF. The treatment will start on the day of
      oocyte retrieval and continue until pregnancy is negative or until week 12 gestation.

      Patients will be followed during treatment until 30 days after delivery to record any safety
      and tolerability data of the patient and their newborn (s).
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>July 2015</start_date>
  <completion_date type="Actual">May 2017</completion_date>
  <primary_completion_date type="Actual">May 2017</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pregnancy rate</measure>
    <time_frame>12 weeks´ gestation</time_frame>
    <description>Pregnancy rate defined as the presence of fetal heart beats at 12 weeks' gestation determined by transvaginal ultrasound.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Positive Pregnancy test rate</measure>
    <time_frame>Day 14 after embryo transfer</time_frame>
    <description>Positive biochemical pregnancy test on Day 14 after embryo transfer</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of successful completion of pregnancy</measure>
    <time_frame>After delivery (about 9 months after IVF)</time_frame>
    <description>Incidence of live births and healthy newborns</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse Events</measure>
    <time_frame>Until Study Completion (about 10 months after IVF)</time_frame>
    <description>Safety and Tolerability data (mother and child)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>physical examination newborn</measure>
    <time_frame>After delivery (about 9 months after IVF)</time_frame>
    <description>The gender</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>physical examination newborn</measure>
    <time_frame>After delivery (about 9 months after IVF)</time_frame>
    <description>APGAR score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>physical examination newborn</measure>
    <time_frame>After delivery (about 9 months after IVF)</time_frame>
    <description>height</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>physical examination newborn</measure>
    <time_frame>After delivery (about 9 months after IVF)</time_frame>
    <description>weight</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>physical examination newborn</measure>
    <time_frame>After delivery (about 9 months after IVF)</time_frame>
    <description>head circumference</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>physical examination on hypospadias of the newborns</measure>
    <time_frame>After delivery (about 9 months after IVF)</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">1066</enrollment>
  <condition>Female Infertility</condition>
  <arm_group>
    <arm_group_label>Dydrogesterone tablets 3x10 mg</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Dydrogesterone tablets 3x10 mg</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Crinone 8% intravaginal progesterone gel 90 mg</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Crinone 8% intravaginal progesterone gel 90 mg</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dydrogesterone 30 mg</intervention_name>
    <description>Oral Dydrogesterone 10 mg tablets tid</description>
    <arm_group_label>Dydrogesterone tablets 3x10 mg</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>intravaginal progesterone gel 90 mg</intervention_name>
    <arm_group_label>Crinone 8% intravaginal progesterone gel 90 mg</arm_group_label>
    <other_name>Crinone 8% intravaginal progesterone gel 90 mg</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Signed informed consent;

          -  Premenopausal females, age &gt; 18 years &lt; 42 years

          -  Non-smokers. For females who were past smokers, they must have stopped tobacco usage
             for at least 3 months prior screening visit

          -  Early follicular phase (Day 2-4) FSH (Follicle stimulating hormone) less than or equal
             to 15 IU/L and estradiol (E2)within normal limits at screening

          -  LH (luteinizing hormone), PRL (prolactin), T (testosterone) and TSH
             (thyroid-stimulating hormone), within the normal limits for the clinical laboratory,
             or considered not clinically significant by the Investigator within 6 months prior or
             at screening

          -  Documented history of infertility (e.g., unable to conceive for at least one year or
             for 6 months for women ≥ 38 years of age or bilateral tubal occlusion or absence)

          -  Normal transvaginal ultrasound at screening (or within 14 days prior of screening)
             without evidence of clinically significant abnormality consistent with finding
             adequate for ART with respect to uterus and adnexa (no hydrosalpinx or clinically
             relevant uterine fibroids)

          -  Subject is not pregnant , confirmed by negative pregnancy or by Investigator Judgement

          -  Clinically indicated protocol for induction of IVF with a fresh embryo

          -  Single or dual embryo transfer

          -  BMI ≥ 18 and ≤ 30 kg/m2

        Exclusion Criteria:

          -  Evidence of cardiovascular, respiratory, urogenital, gastrointestinal/hepatic,
             hematologic/immunologic, HEENT (head, ears, eyes, nose, throat),
             dermatologic/connective tissue, musculoskeletal, metabolic/nutritional, endocrine,
             neurologic/psychiatric, allergy, recent major surgery (&lt; 3 months), or other relevant
             diseases as revealed by history, physical examination and/or laboratory assessments
             which could limit participation in or completion of the study;

          -  Acute urogenital disease

          -  Known allergic reactions to progesterone products

          -  Known allergic reactions to peanuts and peanut oil

          -  Intake of àny experimental drug or any participation in any other clinical trial
             within 30 days prior to study start

          -  Mental disability or any other lack of fitness, in the Investigator's opinion, to
             preclude subjects to participate in or to complete the study

          -  Current or recent substance abuse, including alcohol and tobacco (Note: Patients who
             stopped tobacco usage at least 3 months prior to screening visit would be allowed)

          -  History of chemotherapy or radiotherapy

          -  Patients with more than 3 unsuccessful IVF attempts

          -  Contraindication for pregnancy

          -  Refusal or inability to comply with the requirements of the study protocol for any
             reason, including scheduled clinic visits and laboratory tests

          -  History of recurrent pregnancy loss defined as 3 or more spontaneous miscarriages
             Acute urogenital disease
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>41 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Shreyansh Shah, MD</last_name>
    <role>Study Director</role>
    <affiliation>Abbott</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Melbourne IVF</name>
      <address>
        <city>East Melbourne</city>
        <zip>3002</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>IVF Australia - St George Private HospitalIVF Australia - St George Private Hospital</name>
      <address>
        <city>Kogarah</city>
        <zip>2217</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Univerité Catholique de Louvain, Cliniques universitaires Saint-Luc</name>
      <address>
        <city>Brussels</city>
        <zip>1200</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Algemeen Ziekenhuis Jan Palfijn Gent</name>
      <address>
        <city>Gent</city>
        <zip>9000</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UZ Gent</name>
      <address>
        <city>Gent</city>
        <zip>9000</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitair Ziekenhuis Brussel</name>
      <address>
        <city>Jette</city>
        <zip>1090</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Peking University People's Hospital</name>
      <address>
        <city>Beijing</city>
        <zip>100044</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Reproductive &amp; Genetic Hospital of Citic -Xiangya</name>
      <address>
        <city>Changsha</city>
        <zip>410008</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>West China Second University Hospital</name>
      <address>
        <city>Chengdu</city>
        <zip>610041</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sun Yat-Sen Memorial Hsopiatl, Sun Yat-Sen University</name>
      <address>
        <city>Guangzhou</city>
        <zip>510120</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Sixth Hospital of Sun Yat-Sen University</name>
      <address>
        <city>Guangzhou</city>
        <zip>510655</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The First Affiliate Hospital of Anhui Medical University</name>
      <address>
        <city>Hefei</city>
        <zip>230022</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The First Affiliated Hospital of Nanjing Medical University</name>
      <address>
        <city>Nanjing</city>
        <zip>210029</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tongji Hospital, Tongji Medical College, Huazhong University of Science &amp; Technology</name>
      <address>
        <city>Wuhan</city>
        <zip>430030</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>First Affiliated Hospital of Zhengzhou University</name>
      <address>
        <city>Zhengzhou</city>
        <zip>450052</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fertility Center Berlin</name>
      <address>
        <city>Berlin</city>
        <zip>14050</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bielefeld Fertility Center</name>
      <address>
        <city>Bielefeld</city>
        <zip>33619</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kinderwunschzentrum Dortmund</name>
      <address>
        <city>Dortmund</city>
        <zip>44135</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitäres Kinderwunschzentrum Lübeck</name>
      <address>
        <city>Lübeck</city>
        <zip>23538</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Queen Mary Hospital</name>
      <address>
        <city>Hong Kong</city>
        <country>Hong Kong</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>United CIIGMA Hospital</name>
      <address>
        <city>Aurangabad</city>
        <zip>431005</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>MILANN (Bangalore Assisted Conception Center)</name>
      <address>
        <city>Bangalore</city>
        <zip>560001</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Apollo Hospitals - Bangalore</name>
      <address>
        <city>Bangalore</city>
        <zip>560076</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>All India Institute of Medical Sciences</name>
      <address>
        <city>Delhi</city>
        <zip>110029</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Max Hospital</name>
      <address>
        <city>Delhi</city>
        <zip>110057</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Institute of Reproductive Medicine</name>
      <address>
        <city>Kolkata</city>
        <zip>700014</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ajanta Research Center, Ajanta Hospital and IVF center</name>
      <address>
        <city>Lucknow</city>
        <zip>226005</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Inamdar Multispecialty Hospital</name>
      <address>
        <city>Pune</city>
        <zip>411002</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Shree Hospital and Diagnostic Centre</name>
      <address>
        <city>Pune</city>
        <zip>411006</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CJSC &quot;Center of Family Medicine&quot;</name>
      <address>
        <city>Ekaterinburg</city>
        <zip>620043</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Scientific Research Center of Obstetrics, Gynecology and Perinatology n. a. Ac. V. I. Kulakova</name>
      <address>
        <city>Moscow</city>
        <zip>117997</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CJSC &quot;Nasledniki&quot;</name>
      <address>
        <city>Moscow</city>
        <zip>119192</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saint-Petersburg State Budgetary Healtcare Institution &quot;Maternity Hospital # 17&quot;</name>
      <address>
        <city>Saint-Petersburg</city>
        <zip>193174</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Singapore General Hospital</name>
      <address>
        <city>Singapore</city>
        <zip>169608</zip>
        <country>Singapore</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Songklanagarind Hospital</name>
      <address>
        <city>Bangkok</city>
        <zip>90110</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Maharaj Nakorn Chiang Mai Hospital</name>
      <address>
        <city>Chiang Mai</city>
        <zip>50200</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Centre of Infertility Treatment &quot;Clinic of Professor Yuzko&quot;</name>
      <address>
        <city>Chernivtsi</city>
        <zip>58022</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>&quot;NADIYA&quot; Clinic</name>
      <address>
        <city>Kiev</city>
        <zip>03037</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Institute for Reproductive Medicine in Ukraine</name>
      <address>
        <city>Kiev</city>
        <zip>04107</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>&quot;Mother and Child&quot; clinic</name>
      <address>
        <city>Kiev</city>
        <zip>0411</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Australia</country>
    <country>Belgium</country>
    <country>China</country>
    <country>Germany</country>
    <country>Hong Kong</country>
    <country>India</country>
    <country>Russian Federation</country>
    <country>Singapore</country>
    <country>Thailand</country>
    <country>Ukraine</country>
  </location_countries>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 16, 2015</study_first_submitted>
  <study_first_submitted_qc>July 3, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 8, 2015</study_first_posted>
  <last_update_submitted>October 5, 2017</last_update_submitted>
  <last_update_submitted_qc>October 5, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 6, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infertility</mesh_term>
    <mesh_term>Infertility, Female</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Progesterone</mesh_term>
    <mesh_term>Dydrogesterone</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

